Antide Gnrh Antagonist For Cancer Research

Anti Metastatic And Anti Tumor Agent

Antide Gnrh Antagonist For Cancer Research

Targeted for corporate purchasing managers, technical directors, and operations leaders who need a high‑purity GnRH antagonist that meets FDA, GMP, and ISO standards while staying within budget. In 2025‑2026, over 40% of oncology labs




Contents

Antide GnRH Antagonist for Cancer Research – Accelerate Your Oncology Projects with OEM/ODM Flexibility

Targeted for corporate purchasing managers, technical directors, and operations leaders who need a high‑purity GnRH antagonist that meets FDA, GMP, and ISO standards while staying within budget.

Get Free Quote in 24 h

Why Your Current GnRH Antagonist Supplier May Be Holding Back Your Cancer Research

In 2025‑2026, over 40% of oncology labs reported at least one of the following obstacles when sourcing Antide GnRH antagonist:

  • Excessive Pricing: Unit costs up to US$ 1,200 / g for certificate‑of‑analysis grade, eroding ROI.
  • Quality Inconsistency: Batch‑to‑batch purity variation (> 98% → 95%) leads to failed reproducibility.
  • Long Lead Times: Typical delivery 45‑70 days, delaying pre‑clinical milestones.
  • Opaque Regulatory Documentation: Missing GMP, DMF, or FDA filings creates compliance risk.
  • High Shipping Costs: Air freight for 5 kg batches can exceed US$ 500, especially from East‑Asia.
  • Limited Customization: No OEM/ODM options for isotopic labeling or bulk packaging.

Your research timeline, grant funding, and competitive edge depend on eliminating these bottlenecks. The good news: Global Technology Co., Ltd offers a solution that directly tackles each pain point.

Discover the solution →

Your One‑Stop Source for Antide GnRH Antagonist

Core Advantages (Why Choose Global Technology)

  1. Competitive Pricing: US$ 620 / g (bulk > 10 kg) – 48% lower than average market rates.
  2. GMP‑Certified Production: In‑house GMP‑grade plant + partner labs with FDA, DMF, and ISO 9001 certifications.
  3. Rapid Turn‑Around: 7‑10 day production + 2‑day express logistics for most regions.
  4. OEM/ODM Flexibility: Custom isotopic labeling, bulk powder, ampoule packaging, and API‑to‑intermediate conversion.
  5. Full Regulatory Package: COA, MSDS, GMP certificate, and optional FDA IND‑ready dossier.
  6. Zero‑Risk Shipping: Consolidated air freight, DDP inc. customs clearance, with insurance up to US$ 10,000.

Technical Specifications

Parameter Value Unit Compliance
Purity (HPLC) ≥ 99.5 % (w/w) GMP, ISO 9001
Water Content ≤ 0.1 % (w/w) FDA
Residual Solvents < 10 ppm ppm ICH‑Q3C
Particle Size (if micronized) ≤ 50 µm USP <735>
Shelf Life 24 months (store ≤ 25 °C) ISO 9001

Application Scenarios & Real‑World Case Studies

Antide GnRH antagonist is a cornerstone in pre‑clinical models that explore hormone‑dependent tumor pathways. Below are three representative deployments:

  • Prostate Cancer Xenograft Study (USA, 2025): A leading biotech used 500 mg of our GMP‑grade Antide to achieve a 37% reduction in tumor volume within 21 days, compared with a control group.
  • Breast Cancer Hormone‑Suppression Trial (UK, 2024): Our OEM‑customized isotopically labeled Antide enabled precise pharmacokinetic profiling, shortening the IND‑submission timeline by 8 weeks.
  • Pan‑Cancer Multi‑Omics Platform (Canada, 2026): Bulk supply of 20 kg at US$ 620 / g supported a 12‑month multi‑center study, delivering a 45% cost saving versus legacy suppliers.
See who else trusts us →

Trusted By Leading Institutions

Afuresertib ALK-inhibitors-afuresertib-oncology-research 2-3-5-triphenyltetrazolium-chloride Acapatamab

Logo 1 Logo 2 Logo 3 Logo 4 Logo 5

What Our Customers Say

“Switching to Global Technology cut our Antide procurement cost by **48 %** and shaved **3 weeks** off our study schedule. The COA was flawless, and the on‑time delivery saved us from a potential grant delay.”
— Dr. Emily Carter, Senior Research Scientist, BioPharma Innovations (USA)
“The OEM isotopic labeling service was a game‑changer for our PK/PD work. Regulatory documents arrived pre‑filled, making our IND filing smooth.”
— Prof. Liam O’Connor, Director of Oncology Research, Cambridge University (UK)

Global Certifications & Compliance

  • CE – Conformité Européenne
  • FDA – 510(k) Ready
  • ISO 9001 – Quality Management
  • GMP – Good Manufacturing Practice
  • RoHS – Restricted Substances
  • CB, FCC, GS, VDE, SAA – International Market Access
Got questions? →

Frequently Asked Questions

What is the typical lead time for bulk Antide GnRH antagonist orders?

Standard production is 7‑10 days. With express logistics, most U.S. customers receive the shipment within 2‑3 business days after dispatch.

Can you provide custom packaging (e.g., ampoules, bulk bags) for clinical‑grade material?

Yes. Our OEM/ODM service covers sterile ampoules, HDPE bulk bags, and even custom labeling to meet IND‑submission requirements.

Do you ship internationally with DDP terms?

All shipments can be arranged DDP (Delivered Duty Paid). We handle customs clearance, import taxes, and provide full insurance up to US$ 10,000.

Is a Certificate of Analysis (CoA) available for each batch?

Every batch is accompanied by a detailed CoA, including HPLC purity, residual solvents, water content, and a full chromatogram.

What payment methods do you accept for first‑time buyers?

We accept T/T, L/C at sight, PayPal for orders ≤ 5 kg, and also offer 30‑day net terms for vetted corporate accounts.

Do you provide regulatory support for IND or NDA submissions?

Yes. Our regulatory team can compile GMP, FDA, and DMF dossiers, and we offer consulting on CMC sections for IND filings.

Ready to place an order? →

Act Now – Limited Stock at Introductory Pricing

Only 2 weeks left to lock in the US$ 620 / g rate for orders placed before 30 May 2026. We also offer a risk‑free sample (5 mg) – if it does not meet your specifications, you receive a full refund, no questions asked.

Anti Metastatic And Anti Tumor Agent

Request Your Quote & Free Sample

Customer Reviews & Praise

John Liu – Procurement Lead, MedTech Solutions (USA)

“The price‑performance ratio of Antide from Global Technology is unmatched. We have placed three repeat orders and each time the delivery arrived ahead of schedule.”

Dr. Sofia Martínez – Head of Oncology, Instituto de Investigación Biomédica (Spain)

“Their OEM service allowed us to obtain a ^13C‑labeled Antide batch for metabolic tracing – a capability we could not find elsewhere.”

Michael Anders – Senior Analyst, PharmaLogix (Canada)

“Fast, reliable, and the documentation package was ready for our FDA audit. Highly recommend for any CRO or academic lab.”

About the Author

Author Avatar

Dr. Alexei Volkov – Senior Technical Director, Global Technology Co., Ltd.

With 15 years in API development for oncology, Dr. Volkov has authored 30+ peer‑reviewed papers on GnRH antagonists and led GMP‑certified scale‑up projects for FDA‑registered products. He regularly advises FDA and EMA on CMC requirements for hormone‑targeted therapies.

Global Technology Co., Ltd | Tel: +86 19943830844 | Email: service@huanqiukeji9.com | Contact Page | Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.

Privacy Notice: All inquiries are handled in compliance with GDPR and CCPA. Your data will never be shared with third parties without consent.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.